Latest Breaking News On - Viridian therapeutics - Page 1 : vimarsana.com

Viridian Therapeutics (NASDAQ:VRDN) Trading Down 2 7%

Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) dropped 2.7% during mid-day trading on Wednesday . The company traded as low as $12.97 and last traded at $13.10. Approximately 416,067 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 926,507 shares. The stock had previously closed […]

New yorkUnited statesViridian therapeutics company profileViridian therapeutics incSwiss national bankPrincipal financial group incYork state common retirement fundMirae asset global investments coNeedham companyWolfe researchAmeritas investment partners incViridian therapeuticsGet free reportInvestment partnersNational bankFinancial group

Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management.

United statesGoldman sachsViridian therapeutics incViridian therapeuticsGlobal healthcare conferenceNew yorkAnnual global healthcare conferenceTuesday june

Q2 2024 EPS Estimates for Viridian Therapeutics, Inc (NASDAQ:VRDN) Raised by B Riley

Q2 2024 EPS Estimates for Viridian Therapeutics, Inc (NASDAQ:VRDN) Raised by B Riley
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesSwiss national bankNeedham companyVanguard group incAmeritas investment partners incMirae asset global investments coViridian therapeutics incAmerican international group incViridian therapeuticsFree reportViridian therapeuticGet free reportInternational groupInvestment partnersNational bankMirae asset global investments

Brokers Issue Forecasts for Viridian Therapeutics, Inc s FY2024 Earnings (NASDAQ:VRDN)

Brokers Issue Forecasts for Viridian Therapeutics, Inc s FY2024 Earnings (NASDAQ:VRDN)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankRaymond james associatesAmeritas investment partners incPrincipal financial group incNeedham companyViridian therapeutics incViridian therapeutics company profileViridian therapeuticsFree reportLifesci capitalViridian therapeuticGet free reportInvestment partnersKantonalbank zurich cantonalbankState retirement system

Lifesci Capital Analysts Increase Earnings Estimates for Viridian Therapeutics, Inc (NASDAQ:VRDN)

Lifesci Capital Analysts Increase Earnings Estimates for Viridian Therapeutics, Inc (NASDAQ:VRDN)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Zurcher kantonalbank zurich cantonalbankViridian therapeutics incStonecrest wealth management incSchonfeld strategic advisorsViridian therapeutics company profileColumbus asset advisorsNeedham companyViridian therapeuticsFree reportLifesci capitalViridian therapeuticGet free reportForest capital managementStrategic advisorsCrest wealth managementKantonalbank zurich cantonalbank